特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
949761

遺伝カウンセリングの世界市場 (2019-2030年)

Global Genetic Counseling Market: Focus on Counseling Approach, Key Players Type, Counseling Channel, Type of Service, Application, Target Population, Level of Service, Country Data and Competitive Landscape - Analysis and Forecast, 2019-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
遺伝カウンセリングの世界市場 (2019-2030年)
出版日: 2020年07月10日
発行: BIS Research Inc.
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
担当者のコメント
ゲノム創薬、遺伝子検査の技術の大幅な向上において、適切に遺伝情報を管理し公正な遺伝カウンセリングを実現させることは各国において急務になってきております。BIS Research は、これまでの遺伝カウンセラー統計やインタビューなどを基に、2030年度までの遺伝カウンセリングの世界市場動向をまとめた最新調査レポートを今般リリースいたしました。まずはサンプルページをお送りさせていただきますのでお問合せいただけましたら幸いです。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝カウンセリングの市場は2030年には40億7930万ドルの規模に成長すると予測されています。遺伝カウンセリングサポートサービスは元来、主に遺伝性疾患の発症リスク評価や出生前/受胎前のカウンセリング、小児のリスクケアなどを目的としていましたが、新たな事業者の参入により、薬理ゲノミクス・診断カウンセリングも現在の診断・治療の主だった部分となっています。政府によるイニシアチブや遺伝状況に関する認知度の向上、遺伝カウンセラー数の増加などの要因が同市場の成長を推進しています。

当レポートでは、世界の遺伝カウンセリングの市場を調査し、市場の定義の概要、市場成長への各種影響因子の分析、関連法規制、市場規模の推移・予測、カウンセリングアプローチ・サービスタイプ・用途・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 製品の定義

第2章 市場の範囲

第3章 調査手法

第4章 市場概要

  • 参入事業者・情勢・近年の動向
  • 遺伝カウンセラー統計

第5章 産業分析

  • 遺伝カウンセリング関連法規制:活発な組織
  • ガイドラインと規制
    • 米国
    • 欧州
    • オーストラリア
  • 償還シナリオ
    • 米国
    • 欧州
    • オーストラリア

第6章 市場力学

  • 成長推進因子
  • 成長抑制因子
  • 市場機会

第7章 競合情勢

  • 主な戦略・展開
  • サービスシナリオ
  • 市場シェア分析
  • 成長シェア分析:市場機会マッピング

第8章 市場分析・予測:カウンセリングアプローチ別

  • 統合型遺伝カウンセリング
  • 裁量型遺伝カウンセリング
  • 独立型遺伝カウンセリング

第9章 市場分析・予測:企業のビジネスモデル別

  • コア遺伝カウンセリング企業
  • D2C検査企業
  • 臨床遺伝子検査企業

第10章 市場分析・予測:チャネル別

  • プロバイダー
  • 自己紹介型

第11章 市場分析・予測:サービスタイプ別

  • リスク評価
  • 薬理ゲノミクス
  • その他

第12章 市場分析・予測:用途別

  • 予防的リスク評価
  • ITT (Intent-to-Treat) 患者のGC
  • 出生前・妊娠前ケア
  • 小児ケア
  • その他

第13章 市場分析・予測:人口層別

  • 一般
  • 患者

第14章 市場分析・予測:サービスレベル別

  • カウンセリング前サポート
  • カウンセリング後サポート

第15章 市場分析・予測:地域・主要国別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第16章 企業プロファイル

  • Quest Diagnostics Incorporated
  • Invitae Corporation
  • Laboratory Corporation of America
  • Arup Laboratories
  • Genome Medical
  • MyOncoPath
  • GeneMatters
  • EasyDNA
  • AT-GC
  • Biron Health Group
  • Metis Genetics
  • GeneScreen
  • GeneHealth UK
  • Veritas Genetics
  • InformedDNA
  • Ancestry
  • Color Genomics
  • GeneDX (an Opko Health Company)
  • GenPath Diagnostics (an Opko Health Company)
図表

List of Tables

  • Table 4.1: Global Genetic Counseling Market, by Region, ($Million), 2019-2030
  • Table 4.2: Genetic Counselors Statistics (by Country)
  • Table 5.1: Active Organization for Genetic Counseling
  • Table 5.2: Companies and Relative Coverage Status in the U.S.
  • Table 5.3: Companies and Relative Coverage Status in the Europe
  • Table 5.4: Companies and Relative Coverage Status in the Australia

List of Figures

  • Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Genetic Counseling Market
  • Figure 2: Global Genetic Counseling Market (by Key Players' Business Model), $Million, 2019 and 2030
  • Figure 3: Global Genetic Counseling Market (by Counseling Approach), $Million, 2019 and 2030
  • Figure 4: Global Genetic Counseling Market (by Counseling Channel), $Million, 2019 and 2030
  • Figure 5: Global Genetic Counseling Market (by Type of Service), $Million, 2019 and 2030
  • Figure 6: Global Genetic Counseling Market (by Application), $Million, 2019 and 2030
  • Figure 7: Global Genetic Counseling Market (by Target Population), $Million, 2019 and 2030
  • Figure 8: Global Genetic Counseling Market (by Level of Service), $Million, 2019 and 2030
  • Figure 9: Global Genetic Counseling Market (by Region), $Million, 2019
  • Figure 2.1: Global Genetic Counseling Market Segmentation
  • Figure 3.1: Global Genetic Counseling Market Research Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Global Genetic Counseling Market, 2019-2030 ($Million)
  • Figure 4.2: Genetic Counseling Companies as Per Business Model
  • Figure 4.3: Approaches for Genetic Counseling
  • Figure 4.4: Key Strategies Adopted by Market Players
  • Figure 4.5: Genetic Counselors Statistics and Active Hospital Networks in North America
  • Figure 4.6: Genetic Counselors Statistics and Active Hospital Networks in Europe, APAC, and Rest-of-the-World (RoW)
  • Figure 5.1: Genetic Counseling Guidelines Adopted in the U.S.
  • Figure 5.2: Licensure Status for Genetic Counselors in the U.S.
  • Figure 5.3: HGSA Genetic Counseling Guidelines
  • Figure 5.4: Genetic Counseling Regulatory Authorities in Australia
  • Figure 6.1: Market Dynamics of Global Genetic Counseling Market
  • Figure 6.2: Number of Genetic Counselors in the U.S., 2010-2018
  • Figure 6.3: Synergistic Activities, 2017-2019
  • Figure 7.1: Share of Key Developments and Strategies, January 2017-December 2019
  • Figure 7.2: Synergistic Activities Share (by Company), January 2017-December 2019
  • Figure 7.3: Accreditations Share (by Company), January 2017-December 2019
  • Figure 7.4: Service Launches Share (by Company), January 2017-December 2019
  • Figure 7.5: Acquisitions, Mergers and Spin-offs Share (by Company), January 2017-December 2019
  • Figure 7.6: Genetic Counseling Funding Scenario
  • Figure 7.7: Market Share Analysis for Global Genetic Counseling Market, 2019
  • Figure 7.8: Growth-Share Matrix for Global Genetic Counseling Market (by Company), 2019
  • Figure 7.9: Growth-Share Matrix for Global Genetic Counseling Market (by Target Population), 2019-2030
  • Figure 7.10: Growth-Share Matrix for Global Genetic Counseling Market (by Counseling Approach), 2019-2030
  • Figure 7.11: Growth-Share Matrix for Global Genetic Counseling Market (by Application), 2019-2030
  • Figure 8.1: Global Genetic Counseling Market (by Counseling Approach), 2019 vs. 2030
  • Figure 8.2: Integrated Genetic Counseling Market, $Million, 2019-2030
  • Figure 8.3: Discretionary Genetic Counseling Market, $Million, 2019-2030
  • Figure 8.4: Independent Genetic Counseling Market, $Million, 2019-2030
  • Figure 9.1: Global Genetic Counseling Market (by Key Players' Business Model), 2019 vs 2030
  • Figure 9.2: Genetic Counseling Market by Core Genetic Counseling Segment, $Million, 2019-2030
  • Figure 9.3: Genetic Counseling Market by Direct-to-Consumer Testing Segment, $Million, 2019-2030
  • Figure 9.4: Genetic Counseling Market (by Clinical Genetic Testing Segment), $Million, 2019-2030
  • Figure 10.1: Global Genetic Counseling Market (by Counseling Channel), 2019 vs. 2030
  • Figure 10.2: Genetic Counseling Market by Provider Segment, $Million, 2019-2030
  • Figure 10.3: Genetic Counseling Market by Self-Referred Individuals Segment, $Million, 2019-2030
  • Figure 11.1: Global Genetic Counseling Market (by Type of Service), 2019 vs. 2030
  • Figure 11.2: Genetic Counseling Market by Risk Assessment Segment, $Million, 2019-2030
  • Figure 11.3: Genetic Counseling Market by Pharmacogenomics Segment, $Million, 2019-2030
  • Figure 11.4: Genetic Counseling Market by Other Genetic Counseling Services Segment, $Million, 2019-2030
  • Figure 12.1: Global Genetic Counseling Market (by Application), 2019 vs. 2030
  • Figure 12.2: Indication Risk Assessment Market, $Million, 2019-2030
  • Figure 12.3: Intent-to-treat patients Intent-to-treat Patients Market, $Million, 2019-2030
  • Figure 12.4: Prenatal/Preconception Care Market, $Million, 2019-2030
  • Figure 12.5: Pediatric Care Market, $Million, 2019-2030
  • Figure 12.6: Other GC Applications Market, $Million, 2019-2030
  • Figure 13.1: Global Genetic Counseling Market (by Target Population), 2019 vs. 2030
  • Figure 13.2: Global Genetic Counseling Market by General Population Segment, $Million, 2019-2030
  • Figure 13.3: Global Genetic Counseling Market by Patient Population Segment, $Million, 2019-2030
  • Figure 14.1: Global Genetic Counseling Market (by Level of Service), 2019 vs 2030
  • Figure 14.2: Global Genetic Counseling Market by Pre-counseling Support, $Million, 2019-2030
  • Figure 14.3: Global Genetic Counseling Market by Post-counseling Support, $Million, 2019-2030
  • Figure 15.1: Global Genetic Counseling Market (by Region), $Million, 2019 vs. 2030
  • Figure 15.2: North America: Market Dynamics
  • Figure 15.3: North America Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.4: North America Genetic Counseling Market (by Country), $Million, 2019 vs 2030
  • Figure 15.5: U.S. Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.6: Key Drivers of the U.S. Genetic Counseling Market
  • Figure 15.7: Canada Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.8: Europe: Market Dynamics
  • Figure 15.9: Europe Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.10: Europe Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
  • Figure 15.11: Germany Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.12: U.K. Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.13: France Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.14: Italy Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.15: Spain Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.16: Romania Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.17: Netherlands Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.18: Norway Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.19: Rest-of-Europe Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.20: Asia-Pacific: Market Dynamics
  • Figure 15.21: Asia-Pacific Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.22: Asia-Pacific Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
  • Figure 15.23: China Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.24: Japan Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.25: India Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.26: Taiwan Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.27: New Zealand Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.28: South Korea Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.29: Australia Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.30: Rest-of-APAC Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.31: Rest-of-the-World: Market Dynamics
  • Figure 15.32: Rest-of-the-World Genetic Counseling Market, $Million, 2019-2030
  • Figure 16.1: Total Number of Companies Profiled
  • Figure 16.2: Quest Diagnostics Incorporated: Portfolio
  • Figure 16.3: Quest Diagnostics Incorporated: Overall Financials, 2017-2019
  • Figure 16.4: Quest Diagnostics Incorporated: Revenue (by Business Segment), 2017-2019
  • Figure 16.5: Quest Diagnostics Incorporated: SWOT Analysis
  • Figure 16.6: Invitae Corporation: Portfolio
  • Figure 16.7: Invitae Corporation: Overall Financials, 2017-2019
  • Figure 16.8: Invitae Corporation: Revenue (by Segment), 2017-2019
  • Figure 16.9: Invitae Corporation: Revenue (by Geography), 2017-2019
  • Figure 16.10: Invitae Corporation: R&D Expenditure, 2017-2019
  • Figure 16.11: Invitae Corporation: SWOT Analysis
  • Figure 16.12: Laboratory Corporation of America Holdings: Service Portfolio
  • Figure 16.13: Laboratory Corporation of America Holdings: Overall Financials, 2017-2019
  • Figure 16.14: Laboratory Corporation of America Holdings: Revenue (by Segment), 2017-2019
  • Figure 16.15: Laboratory Corporation of America Holdings: Revenue (by Region), 2019
  • Figure 16.16: Laboratory Corporation of America Holdings: SWOT Analysis
  • Figure 16.17: ARUP Laboratories: SWOT Analysis
  • Figure 16.18: Genome Medical: SWOT Analysis
  • Figure 16.19: MyOncoPath: SWOT Analysis
  • Figure 16.20: GeneMatters: SWOT Analysis
  • Figure 16.21: EasyDNA: SWOT Analysis
  • Figure 16.22: AT-GC: SWOT Analysis
  • Figure 16.23: Biron Health Group: SWOT Analysis
  • Figure 16.24: Metis Genetics: SWOT Analysis
  • Figure 16.25: Gene Screen: SWOT Analysis
  • Figure 16.26: GeneHealth UK: SWOT Analysis
  • Figure 16.27: Veritas Genetics: SWOT Analysis
  • Figure 16.28: Informed DNA: SWOT Analysis
  • Figure 16.29: Ancestry: SWOT Analysis
  • Figure 16.30: Color Genomics: SWOT Analysis
  • Figure 16.31: GeneDX: SWOT Analysis
  • Figure 16.32: GenPath Diagnostics: SWOT Analysis
目次
Product Code: BHP0939SA

"Global Genetic Counseling Market to Reach $4,079.3 Million by 2030."

Market Segmentation

  • By Key Players Business Model: Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, and Clinical Genetic Testing Companies
  • By Counseling Approach: Integrated, Independent, and Discretionary Genetic Counseling
  • By Level of Service: Pre- and Post-Genetic Counseling Services
  • By Target Population: General Population and Intent-to-Treat Patient Population
  • By Type of Service: Risk Assessment Counseling and Pharmacogenomic Counseling
  • By Type of Application: Prenatal/Preconception Care, Pediatric Care, Indication Risk Assessment, and Genetic Counseling for Intent-to-Treat Patients
  • By Type of Counseling Channel: Providers and Self-Referred Individuals
  • By Region: North America, Europe, Asia Pacific, and Rest-of-the-World

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Romania, Netherlands, Norway, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, Taiwan, New Zealand, South Korea, Australia, Rest-of-APAC
  • Rest-of-the-World

Growth Drivers

  • Rapid Rise in Number of Genetic Counselors' Workforce
  • Increasing Adoption of Inorganic Growth Strategies in the Market
  • Rising Demand of Prenatal and Preconception Genetic Support Services in Major Geographies

Market Challenges

  • Limited Reimbursement Among Major Insurance Providers
  • Lack of Genetic Counselors

Market Opportunities

  • Healthcare Costs Mitigation
  • Expected Implementation of H.R. 3235 Bill in the U.S.
  • Entry of New Genetic Counseling Platforms to Maximize Counselors' Productivity

Key Genetic Counseling Companies Profiled

InformedDNA, Integrated Genetics (Laboratory Corporation of America), Quest Diagnostics Incorporated, Genome Medical, ARUP Laboratories, Invitae Corporation, GeneMatters, and MyOncoPath.

Key Questions Answered in this Report:

  • What is genetic counseling? How different settings for genetic counseling has evolved over the centuries?
  • What are the major market drivers, challenges, and opportunities in the global genetic counseling market?
  • What was the global genetic counseling market size in terms of revenue in 2019? How is the market expected to evolve in the upcoming years? What is the expected market size in 2030?
  • How is each segment of the global genetic counseling market expected to grow during the forecast period between 2020 to 2030, and what revenue is expected to be generated by each of the segments by the end of 2030?
  • What are the developmental strategies implemented by the key players to sustain in the competitive market?
  • What is the growth potential of the global genetic counseling in several countries globally?
  • Which service segment among the four (proactive indication risk assessment, prenatal/preconception, pediatric, or pharmacogenomic) are offered by key players such as Integrated Genetics (Laboratory Corporation of America), InformedDNA, Genome Medical, Quest Diagnostics Incorporated, MyOncoPath, among others?
  • Which genetic counseling approach was leading the market in 2019 and is expected to dominate the market in 2030, and why?
  • Which application type is leading the market in 2019 and is expected to dominate the market in 2030 and why?
  • Which region dominated the global genetic counseling market in 2019, and what are the expected trends from each of the regions in the forecast period 2020-2030?

Market Overview

Genetic Counseling is a communication process that intends to assist at-risk or affected individuals and families in understanding the disease risks, mode of transmission, and natural history of a genetic disorder. The approach also facilitates informed consent for genetic tests when required, in settings such as family planning and risk management services.

Traditionally, the genetic counseling support services had mainly been offered for settings such as indication risk assessment and other segments of prenatal/preconception, and pediatric risk care. However, with the advent of new players in the genetic counseling market, pharmacogenomic services and diagnostic counseling services have become an eminent part of current diagnostic and treatment practices. Several players, such as Genome Medical and MyOncoPath, are currently offering these services in the market. The entry of new players in the market, coupled up with increased innovation pertaining to cost mitigation and resource output maximization had transformed the market currently.

The existing market of genetic counseling is favored by multiple factors, which include rising government initiatives, coupled up with general population's growing awareness pertaining to genetic conditions. Additionally, the increasing number of genetic counselors in both industry and hospital settings is also one of the key driving factors for genetic counseling market.

Within the research report, the market is segmented on the basis of key players business model (core genetic counseling company, clinical genetic testing company, and direct-to-consumer testing company), genetic counseling approach (integrated counseling, discretionary counseling, and independent counseling services), level of counseling (pre- and post-counseling support), target population (general population and patients), type of service (risk assessment counseling and pharmacogenomic counseling), application( prenatal/preconception care, pediatric care, indication risk assessment, and genetic counseling for intent-to-treat patients), counseling channel (providers and self-referred individuals) and region (North America, Europe, Asia Pacific and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.

Competitive Landscape

Major players, including Genome Medical, GeneMatters, Fulgent Genetics, and InformedDNA, among others, led the number of synergistic developments (partnerships and alliances) witnessed by the market. On the basis of region, North America is expected to retain a leading position throughout the forecast period 2020-2030, followed by Europe. This is a result of the presence of leading industry players in this region, coupled up with a rising number of genetic conditions.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Market Scope

  • 2.1 Scope of Work
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Global Genetic Counseling Market: Research Methodology
  • 3.2 Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model
  • 3.5 Criteria for Company Profiling

4 Market Overview

  • 4.1 Industry Participants, Landscape, and Recent Trends
  • 4.2 Genetic Counselors Statistics

5 Industry Insights

  • 5.1 Active Organizations for Genetic Counseling Regulation
  • 5.2 Guidelines and Regulation for Genetic Counseling
    • 5.2.1 U.S.
      • 5.2.1.1 Guidelines
      • 5.2.1.2 Regulation
    • 5.2.2 Europe
      • 5.2.2.1 Guidelines
      • 5.2.2.2 Regulation
    • 5.2.3 Australia
      • 5.2.3.1 Guidelines
      • 5.2.3.2 Regulation
  • 5.3 Reimbursement Scenario
    • 5.3.1 U.S.
    • 5.3.2 Europe
    • 5.3.3 Australia

6 Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Rapid Rise in Number of Genetic Counselors Workforce
    • 6.1.2 Increasing Adoption of Inorganic Growth Strategies in the Market
    • 6.1.3 Rising Demand of Prenatal and Preconception Genetic Support Services in Major Geographies
  • 6.2 Restraints
    • 6.2.1 Limited Reimbursement Among Major Insurance Providers
    • 6.2.2 Lack of Genetic Counselors
  • 6.3 Market Opportunities
    • 6.3.1 Healthcare Costs Mitigation
    • 6.3.2 Expected Implementation of H.R. 3235 Bill in the U.S.
    • 6.3.3 Entry of New Genetic Counseling Platforms to Maximize Counselors' Productivity

7 Competitive Landscape

  • 7.1 Key Strategies and Developments
    • 7.1.1 Synergistic Activities
    • 7.1.2 Regulatory Accreditations
    • 7.1.3 Service Launches
    • 7.1.4 Acquisitions, Mergers and Spin-offs
  • 7.2 Service Scenario
    • 7.2.1 Funding Scenario
  • 7.3 Market Share Analysis
  • 7.4 Growth-Share Analysis (Opportunity Mapping)
    • 7.4.1 By Company
    • 7.4.2 By Target Population
    • 7.4.3 By Counseling Approach
    • 7.4.4 By Application

8 Global Genetic Counseling Market (by Counseling Approach)

  • 8.1 Integrated Genetic Counseling
  • 8.2 Discretionary Genetic Counseling
  • 8.3 Independent Genetic Counseling

9 Global Genetic Counseling Market (by Key Players Business Model)

  • 9.1 Core Genetic Counseling Companies
  • 9.2 Direct-to-Consumer Testing Companies
  • 9.3 Clinical Genetic Testing Companies

10 Global Genetic Counseling Market (by Channel)

  • 10.1 Providers
  • 10.2 Self-Referred Individuals

11 Global Genetic Counseling Market (by Type of Service)

  • 11.1 Risk Assessment
  • 11.2 Pharmacogenomics
  • 11.3 Other Genetic Counseling Services

12 Global Genetic Counseling Market (by Application)

  • 12.1 Proactive Risk Assessment
  • 12.2 GC For Intent-to-Treat Patients (ITT)
  • 12.3 Prenatal and Preconception Care
  • 12.4 Pediatric Care
  • 12.5 Other Genetic Counseling Applications

13 Global Genetic Counseling Market (by Target Population Segment)

  • 13.1 General Population
  • 13.2 Patient Population

14 Global Genetic Counseling Market (by Level of Service)

  • 14.1 Pre-counseling Support
  • 14.2 Post Counseling Support

15 Global Genetic Counseling Market (by Region)

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 U.S.
    • 15.2.2 Canada
  • 15.3 Europe
    • 15.3.1 Germany
    • 15.3.2 U.K.
    • 15.3.3 France
    • 15.3.4 Italy
    • 15.3.5 Spain
    • 15.3.6 Romania
    • 15.3.7 Netherlands
    • 15.3.8 Norway
    • 15.3.9 Rest-of-Europe
  • 15.4 Asia-Pacific
    • 15.4.1 China
    • 15.4.2 Japan
    • 15.4.3 India
    • 15.4.4 Taiwan
    • 15.4.5 New Zealand
    • 15.4.6 South Korea
    • 15.4.7 Australia
    • 15.4.8 Rest-of-APAC
  • 15.5 Rest-of-the-World

16 Company Profiles

  • 16.1 Overview
  • 16.2 Quest Diagnostics Incorporated
    • 16.2.1 Company Overview
    • 16.2.2 Role of Quest Diagnostics Incorporated in the Global Genetic Counseling Market
    • 16.2.3 Financials
    • 16.2.4 SWOT Analysis
  • 16.3 Invitae Corporation
    • 16.3.1 Company Overview
    • 16.3.2 Role of Invitae Corporation, Inc. in the Global Genetic Counseling Market
    • 16.3.3 Financials
    • 16.3.4 SWOT Analysis
  • 16.4 Laboratory Corporation of America
    • 16.4.1 Company Overview
    • 16.4.2 Role of Laboratory Corporation of America Holdings in the Global Genetic Counseling Market
    • 16.4.3 Financials
    • 16.4.4 SWOT Analysis
  • 16.5 Arup Laboratories
    • 16.5.1 Company Overview
    • 16.5.2 Role of ARUP Laboratories in the Global Genetic Counseling Market
    • 16.5.3 SWOT Analysis
  • 16.6 Genome Medical
    • 16.6.1 Company Overview
    • 16.6.2 Role of Genome Medical in the Global Genetic Counseling Market
    • 16.6.3 SWOT Analysis
  • 16.7 MyOncoPath
    • 16.7.1 Company Overview
    • 16.7.2 Role of MyOncoPath in the Genetic Counseling Market
    • 16.7.3 SWOT Analysis
  • 16.8 GeneMatters
    • 16.8.1 Company Overview
    • 16.8.2 Role of GeneMatters in the Genetic Counseling Market
    • 16.8.3 SWOT Analysis
  • 16.9 EasyDNA
    • 16.9.1 Company Overview
    • 16.9.2 Role of EasyDNA in the Global Genetic Counseling Market
    • 16.9.3 SWOT Analysis
  • 16.1 AT-GC
    • 16.10.1 Company Overview
    • 16.10.2 Role of AT-GC in the Global Genetic Counseling Market
    • 16.10.3 SWOT Analysis
  • 16.11 Biron Health Group
    • 16.11.1 Company Overview
    • 16.11.2 Role of Biron Health Group in the Global Genetic Counseling Market
    • 16.11.3 SWOT Analysis
  • 16.12 Metis Genetics
    • 16.12.1 Company Overview
    • 16.12.2 Role of Metis Genetics in the Global Genetic Counseling Market
    • 16.12.3 SWOT Analysis
  • 16.13 GeneScreen
    • 16.13.1 Company Overview
    • 16.13.2 Role of GeneScreen in the Global Genetic Counseling Market
    • 16.13.3 SWOT Analysis
  • 16.14 GeneHealth UK
    • 16.14.1 Company Overview
    • 16.14.2 Role of GeneHealth UK in the Global Genetic Counseling Market
    • 16.14.3 SWOT Analysis
  • 16.15 Veritas Genetics
    • 16.15.1 Company Overview
    • 16.15.2 Role of Veritas Genetics in the Global Genetic Counseling Market
    • 16.15.3 SWOT Analysis
  • 16.16 InformedDNA
    • 16.16.1 Company Overview
    • 16.16.2 Role of InformedDNA in the Global Genetic Counseling Market
    • 16.16.3 SWOT Analysis
  • 16.17 Ancestry
    • 16.17.1 Company Overview
    • 16.17.2 Role of Ancestry in the Global Genetic Counseling Market
    • 16.17.3 SWOT Analysis
  • 16.18 Color Genomics
    • 16.18.1 Company Overview
    • 16.18.2 Role of Color Genomics in the Global Genetic Counseling Market
    • 16.18.3 SWOT Analysis
  • 16.19 GeneDX (an Opko Health Company)
    • 16.19.1 Company Overview
    • 16.19.2 Role of GeneDX in the Global Genetic Counseling Market
    • 16.19.3 SWOT Analysis
  • 16.2 GenPath Diagnostics (an Opko Health Company)
    • 16.20.1 Company Overview
    • 16.20.2 Role of GenPath Diagnostics in the Global Genetic Counseling Market
    • 16.20.3 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.